Sofosbuvir/Ombitasvir/Paritaprevir/ Ritonavir and Ribavirin for Hepatitis C Virus Genotype 4 Patients

NCT04391985 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

113

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C Virus Infection

Interventions

DRUG: SOF plus (OBV/PTV/r) plus RBV

Sponsor

Beni-Suef University